Significance of Interleukin 23 in Systemic Lupus Patients: Relation to Disease Activity and Damage Indices.

Maysa M Haroon Gehan A Hegazy Mohammed A Hassanien Olfat Gamil Shaker Wafaa H Hussein

Published in: Biologics : targets & therapy (2023)

IL23 has higher levels in the serum of SLE patients, and is correlated to activity of the disease, especially lupus nephritis. Further researchis needed to explore its exact role in SLE pathogenesis and whether it can be considered a potential biomarker or therapeutic target in SLE.

Keyphrases

disease activity
systemic lupus erythematosus
end stage renal disease
rheumatoid arthritis
newly diagnosed
ejection fraction
chronic kidney disease
rheumatoid arthritis patients
ankylosing spondylitis
prognostic factors
peritoneal dialysis
oxidative stress
juvenile idiopathic arthritis
density functional theory